| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tanespimycin:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | GSK-J4 | CTRPv2 | pan-cancer | AAC | -0.037 | 0.8 |
| mRNA | avrainvillamide | CTRPv2 | pan-cancer | AAC | -0.013 | 0.8 |
| mRNA | CGP-082996 | GDSC1000 | pan-cancer | AAC | -0.017 | 0.8 |
| mRNA | Sorafenib | GDSC1000 | pan-cancer | AAC | -0.018 | 0.8 |
| mRNA | 17-AAG | GDSC1000 | pan-cancer | AAC | 0.0099 | 0.8 |
| mRNA | JNJ-26854165 | GDSC1000 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | ML334 diastereomer | CTRPv2 | pan-cancer | AAC | 0.014 | 0.8 |
| mRNA | hyperforin | CTRPv2 | pan-cancer | AAC | 0.012 | 0.8 |
| mRNA | thapsigargin | GDSC1000 | pan-cancer | AAC | 0.011 | 0.8 |